Inventor · disambiguated record
Michael Dewitt Culler
Also filed as: CULLER MICHAEL · CULLER MICHAEL D · CULLER MICHAEL DE WITT · CULLER MICHAEL DEWITT
26 granted patents·15 pending applications·254 citations·filing 1984–2024
96Inventor score
Files withIPSEN PHARMA SAS11SOD CONSEILS RECH APPLIC6DONG ZHENG XIN4BIOMEASURE INC2CULLER MICHAEL D2
Top patents by PatentIndex Score
41 records- 0193US7572883B2Somatostatin-dopamine chimeric analogsSOD CONSEILS RECH APPLIC·Filed 2006·Granted Aug 11, 2009·18 cites·8 claims
- 0291US8324386B2Somatostatin-dopamine chimeric analogsCULLER MICHAEL D·Filed 2009·Granted Dec 4, 2012·16 cites·7 claims
- 0390US8178651B2Somatostatin-dopamine chimeric analogsCULLER MICHAEL D·Filed 2009·Granted May 15, 2012·16 cites·14 claims
- 0489US7579435B2Somatostatin-dopamine chimeric analogsSOD CONSEILS RECH APPLIC·Filed 2002·Granted Aug 25, 2009·25 cites·7 claims
- 0587US8822442B2Somatostatin-dopamine chimeric analogsDONG ZHENG XIN·Filed 2005·Granted Sep 2, 2014·12 cites·28 claims
- 0685US9155777B2Use of melanocortins to treat insulin sensitivityHALEM HEATHER A·Filed 2008·Granted Oct 13, 2015·10 cites·10 claims
- 0785US8871706B2Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogueDONG ZHENG XIN·Filed 2008·Granted Oct 28, 2014·6 cites·6 claims
- 0884US8076281B2Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatmentTULIPANO GIOVANNI·Filed 2008·Granted Dec 13, 2011·9 cites·20 claims
- 0984US7517853B2Somatostatin-dopamine chimeric analogsIPSEN PHARMA SAS·Filed 2004·Granted Apr 14, 2009·19 cites·2 claims
- 1083US6787521B2Method of inhibiting fibrosis with a somatostatin agonistSOD CONSEILS RECH APPLIC·Filed 2001·Granted Sep 7, 2004·14 cites·2 claims
- 1182US8236762B2Peptide-cytotoxic conjugatesDONG ZHENG XIN·Filed 2007·Granted Aug 7, 2012·6 cites·28 claims
- 1278US8741835B2Use of a ghrelin agonist to improve the catabolic effects of glucocorticoid treatmentTULIPANO GIOVANNI·Filed 2011·Granted Jun 3, 2014·4 cites·10 claims
- 1378US2022339239A1Use of melanocortins to treat insulin sensitivityIPSEN PHARMA SAS·Filed 2022·Application pending·0 cites
- 1474US9827286B2Use of melanocortins to treat insulin sensitivityIPSEN PHARMA SAS·Filed 2016·Granted Nov 28, 2017·1 cites·10 claims
- 1572US9439943B2Use of melanocortins to treat insulin sensitivityIPSEN PHARMA SAS·Filed 2015·Granted Sep 13, 2016·1 cites·17 claims
- 1670US8258094B2Analogs of ghrelinDONG ZHENG XIN·Filed 2008·Granted Sep 4, 2012·1 cites·80 claims
- 1770US6268342B1Method of inhibiting fibrosis with a somatostatin agonistBIOMEASURE INC·Filed 1997·Granted Jul 31, 2001·28 cites·29 claims
- 1870US4562175ASynthetic peptidesCHANG DING·Filed 1984·Granted Dec 31, 1985·27 cites·4 claims
- 1967US2020360483A1METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUEIPSEN PHARMA SAS·Filed 2020·Application pending·0 cites
- 2065US7238666B2Method of inhibiting fibrosis with a somatostatin agonistSOD CONSEILS RECH APPLIC·Filed 2004·Granted Jul 3, 2007·0 cites·38 claims
- 2164US2019111105A1Use of Melanocortins to Treat Insulin SensitivityIPSEN PHARMA SAS·Filed 2018·Application pending·0 cites
- 2263US7084117B2Pharmaceutical compositions which inhibit vascular proliferation and method of use thereofSOD CONSEILS RECH APPLIC·Filed 2002·Granted Aug 1, 2006·5 cites·12 claims
- 2363US2015111823A1METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUEIPSEN PHARMA SAS·Filed 2014·Application pending·0 cites
- 2460US2018303899A1Use of Melanocortins to Treat Insulin SensitivityIPSEN PHARMA SAS·Filed 2017·Application pending·0 cites
- 2559US2025032590A1Parathyroid hormone compounds in the treatment of hypoparathyroidismAMOLYT PHARMA·Filed 2024·Application pending·0 cites
- 2659US2017304403A1METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUEIPSEN PHARMA SAS·Filed 2017·Application pending·0 cites
- 2759US2011183416A1Method of modulating the proliferation of medullary thyroid carcinoma cellsUBERTI ETTORE CIRO DEGLI·Filed 2007·Application pending·0 cites
- 2855US2016206700A1METHOD FOR INHIBITING INFLAMMATION and PRO-INFLAMMATORY CYTOKINE/CHEMOKINE EXPRESSION USING A GHRELIN ANALOGUEIPSEN PHARMA SAS·Filed 2016·Application pending·0 cites
- 2953US7094753B2Somatostatin analog and uses thereofSOD CONSEILS RECH APPLIC·Filed 2002·Granted Aug 22, 2006·0 cites·1 claims
- 3053US5686418AProlonging survival of transplanted pancreatic cellsBIOMEASURE INC·Filed 1996·Granted Nov 11, 1997·10 cites·21 claims
- 3151US2006069017A1Somatostatin analog and uses thereofGORDON THOMAS D·Filed 2005·Application pending·0 cites
- 3250US2005124549A1Method of modulating the proliferation of medullary thyroid carcinoma cellsFiled 2002·Application pending·0 cites
- 3348US2013331324A1Use of melanocortins to treat dyslipidemiaIPSEN PHARMA SAS·Filed 2013·Application pending·0 cites
- 3447US2009099094A1Use of Somatostatin Agonists to Treat Medullary Thyroid CarcinomaZATELLI MARJA CHIARA·Filed 2007·Application pending·0 cites
- 3543US6342479B1Prolonging survival of transplanted pancreatic cellsCOUNSEILS DE RECH S ET D APPLI·Filed 1997·Granted Jan 29, 2002·9 cites·16 claims
- 3642US5972893AMethod of treating hyperprolactinemia and prolactinomasCEDARS SINAI MEDICAL CENTER·Filed 1997·Granted Oct 26, 1999·10 cites·44 claims
- 3742US2004198653A1Pharmaceutical compositions which inhibit proliferation of pituitary adenomas and method of use thereofFiled 2002·Application pending·0 cites
- 3838US2012135923A1Use of Melanocortins to Treat DyslipidemiaHALEM HEATHER A·Filed 2010·Application pending·0 cites
- 3931US5593842AMethod of measuring thymopoietin proteins in plasma and serum including acidification of the plasma and serumGOLDSTEIN GIDEON·Filed 1994·Granted Jan 14, 1997·2 cites·11 claims
- 4031US5591588AMethod for the diagnosis of depression based on monitoring blood levels of arginine vasopressin and/or thymopoietinGOLDSTEIN GIDEON·Filed 1994·Granted Jan 7, 1997·2 cites·8 claims
- 4131US5472856ARecombinant human thymopoietin proteins and uses thereforIMMUNOBIOLOGY RES INST INC·Filed 1993·Granted Dec 5, 1995·3 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →